A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)

Completed · Not applicable

Conditions studied: Healthy

In brief

The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.

Key facts

Study ID

NCT00347594

Run by

Bausch & Lomb Incorporated

People needed

76

Starts

2005-08-01

Expected to finish

2006-09-01

Last updated by the study team

2014-01-17

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• +10.00D to -20.00D of absolute spherical ametropia
• Must be part of the Bausch \& Lomb research clinic
• Snellen visual acuity must be correctable to 20/25

You may not qualify if…

• No more than -6.00D of refractive astigmatism

Where it is running

• Bausch & Lomb — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.